These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 471867)
1. Epsilon aminocaproic acid (EACA) myopathy. Lane RJ; McLelland NJ; Martin AM; Mastaglia FL Postgrad Med J; 1979; 55(642):282-5. PubMed ID: 471867 [TBL] [Abstract][Full Text] [Related]
2. Epsilon-aminocaproic acid-induced myopathy. A case report. Morris CD; Jacobs P; Berman PA; Rutherfoord GS S Afr Med J; 1983 Sep; 64(10):363-6. PubMed ID: 6612533 [TBL] [Abstract][Full Text] [Related]
3. Myopathy induced by epsilon-aminocaproic acid. Case report. Brown JA; Wollmann RL; Mullan S J Neurosurg; 1982 Jul; 57(1):130-4. PubMed ID: 7086489 [TBL] [Abstract][Full Text] [Related]
4. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review. Galassi G; Gibertoni M; Corradini L; Colombo A Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249 [TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Britt CW; Light RR; Peters BH; Schochet SS Arch Neurol; 1980 Mar; 37(3):187-8. PubMed ID: 7356431 [TBL] [Abstract][Full Text] [Related]
6. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. MacKay AR; Sang U H; Weinstein PR J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689 [TBL] [Abstract][Full Text] [Related]
7. Epsilon-aminocaproic acid myopathy. Report of a case and literature review. Vanneste JA; van Wijngaarden GK Eur Neurol; 1982; 21(4):242-8. PubMed ID: 7117311 [TBL] [Abstract][Full Text] [Related]
8. Epsilon amino caproic acid myopathy: additional features. Van Renterghem D; De Reuck J; Schelstraete K; Elinck W; Van der Straeten M Clin Neurol Neurosurg; 1984; 86(3):153-7. PubMed ID: 6091962 [TBL] [Abstract][Full Text] [Related]
9. Acute renal failure and myopathy after treatment with aminocaproic acid. Biswas CK; Milligan DA; Agte SD; Kenward DH; Tilley PJ Br Med J; 1980 Jul; 281(6233):115-6. PubMed ID: 7427206 [No Abstract] [Full Text] [Related]
11. Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature. Kane MJ; Silverman LR; Rand JH; Paciucci PA; Holland JF Am J Med; 1988 Dec; 85(6):861-3. PubMed ID: 3057905 [No Abstract] [Full Text] [Related]
12. Myopathy due to epsilon amino-caproic acid. Kennard C; Swash M; Henson RA Muscle Nerve; 1980; 3(3):202-6. PubMed ID: 6990256 [TBL] [Abstract][Full Text] [Related]
13. epsilon-Aminocaproic acid-associated myopathy in a child. Winter SS; Chaffee S; Kahler SG; Graham ML J Pediatr Hematol Oncol; 1995 Feb; 17(1):53-5. PubMed ID: 7743238 [TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition. Burchiel KJ; Hoffman JM; Bakay RA Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999 [TBL] [Abstract][Full Text] [Related]
16. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report. Tubbs RR; Benjamin SP; Dohn DE J Neurosurg; 1979 Jul; 51(1):94-7. PubMed ID: 448423 [TBL] [Abstract][Full Text] [Related]
17. Purpuric rash due to epsilon-aminocaproic acid. Chakrabarti A; Collett KA Br Med J; 1980 Jul; 281(6234):197-8. PubMed ID: 6447530 [No Abstract] [Full Text] [Related]
18. Acute delirious state after epsilon-aminocaproic acid. Wysenbeek AJ; Sella A; Vardi M; Yeshurun D Lancet; 1978 Jan; 1(8057):221. PubMed ID: 74653 [No Abstract] [Full Text] [Related]
19. Epsilon-aminocaproic acid myopathy. Randall J; Taylor K Aust N Z J Med; 1990 Dec; 20(6):851. PubMed ID: 2291739 [No Abstract] [Full Text] [Related]